[url=https://www.bloomberg.com/news/features/2019-06-13/the-u-s-is-purging-chinese-americans-from-top-cancer-research]https://www.bloomberg.com/news/features/2019-06-13/the-u-s-is-purging-chinese-americans-from-top-cancer-research[/url] It contained findings that she’d improperly shared confidential information and accepted a half-dozen advisory roles at medical institutions in China.
One of the program’s tag lines: “Cancer knows no borders.”
Except, it turns out, the borders around China. In January, Wu, an award-winning epidemiologist and naturalized American citizen, quietly stepped down as director of the Center for Public Health and Translational Genomics at the University of Texas MD Anderson Cancer Center after a three-month investigation into her professional ties in China. Her resignation, and the departures in recent months of three other top Chinese American scientists from Houston-based MD Anderson, stem from a Trump administration drive to counter Chinese influence at U.S. research institutions. The aim is to stanch China’s well-documented and costly theft of U.S. innovation and know-how. The collateral effect, however, is to stymie basic science, the foundational research that underlies new medical treatments. Everything is commodified in the economic cold war with China, including the struggle to find a cure for cancer.
[url=https://www.bloomberg.com/news/features/2019-06-13/the-u-s-is-purging-chinese-americans-from-top-cancer-research]https://www.bloomberg.com/news/features/2019-06-13/the-u-s-is-purging-chinese-americans-from-top-cancer-research[/url] It contained findings that she’d improperly shared confidential information and accepted a half-dozen advisory roles at medical institutions in China.
One of the program’s tag lines: “Cancer knows no borders.”
Except, it turns out, the borders around China. In January, Wu, an award-winning epidemiologist and naturalized American citizen, quietly stepped down as director of the Center for Public Health and Translational Genomics at the University of Texas MD Anderson Cancer Center after a three-month investigation into her professional ties in China. Her resignation, and the departures in recent months of three other top Chinese American scientists from Houston-based MD Anderson, stem from a Trump administration drive to counter Chinese influence at U.S. research institutions. The aim is to stanch China’s well-documented and costly theft of U.S. innovation and know-how. The collateral effect, however, is to stymie basic science, the foundational research that underlies new medical treatments. Everything is commodified in the economic cold war with China, including the struggle to find a cure for cancer.
世事如棋 发表于 3/2/2020 12:14:38 AM [url=https://forums.huaren.us/showtopic.aspx?topicid=2513026&postid=82972641#82972641][img][/img][/url]
Yea...just wonder if there more behind the scene. She still approves the American approach though, understandably.
[url=https://mp.weixin.qq.com/s/yL-d4i54AOk409rfmthGLQ]https://mp.weixin.qq.com/s/yL-d4i54AOk409rfmthGLQ[/url]
吴息凤此前为德州大学MD安德森癌症中心教授，兼任德克萨斯大学公共卫生学院流行病学教授，并曾在2011年至2015担任该校流行病学系系主任和流行病学学科负责人。在接受《知识分子》的访谈中，她就国内新冠肺炎疫情研判、美国突发公共卫生事件防御体系如何运转、公共卫生人才如何培养，以及疾控中心人员的科研水平、薪资如何提高等问题，谈了自己的看法和思考。
此次国内在应对疫情上的短板也是显而易见的，如在疫情的早期研判、信息的及时公布、应急物资的储备，医护人员的保护等方面。
“我们应该要下定决心进行彻底有效的改革，让公卫在疫情防控中真正发挥作用。” 吴息凤说。她指出，要让疫情的防控 “依靠专家、依靠科学”，要“增加疾控中心专业话语权和一定的决策权”。在重大的公共卫生事件处理过程中，“需要在第一时间（be first）、正确的（be right）、可靠的（be credible）的风险沟通”。
......
(介绍美国经验)
吴息凤：
在美国，部分高校的公共卫生学院、美国CDC等机构共同成立了学术公共卫生实践联系委员会，委员会制定了“公共卫生专业人员核心能力”体系，为所有从事公共卫生的人员制定了8个领域的68种核心能力，这里的核心能力代表为充分提供 “基本公共卫生服务” 所必须的一系列个人技能。这些核心能力也能够确保从事公共卫生的各级人员能够很好的应对公共健康危机。比如，公共健康危机来临时，及时有效的沟通很重要，无论是公卫专家与政府还是与民众之间，尽早采取措施，可以达到最大的防控效果，而经济和社会的损失最小。美国CDC是一个独立的联邦机构，受卫生行政部门的指导，但不是领导。所以他们的自主权更大一些，也可以独立发布疫情信息。因此，他们更能够和政府其他部门及时的沟通、以及根据专业判断给出处理相关公共卫生事件的策略和措施。
对于我国而言，首先需要高度重视公共卫生和疾病防控系统建设，全面提升公共卫生和疾病防控系统在国家卫生体系中的功能定位。疾控中心可参照专业性的行政机构管理，赋予对外发布公共卫生领域内的相关信息和数据的权利，与其它卫生部门一起参与决策，提高信息的时效性和有效性。
......
美国的公共卫生系统在全球处于领先水平。美国也有很多世界顶尖高校，如约翰霍普金斯大学、哈佛大学等都设有公共卫生学院，且约翰霍普金斯大学是全球最早设立公共卫生学院的学校。因此，美国的公共卫生人才，无论在待遇和地位上，都有很好的保障。
......
因此，对于中国的公卫体系，一方面需要加强公卫人才的培养并保障他们的待遇；另一方面要加强跨学科领域的合作，深化公卫与临床等学科的交流，促进共同发展。
美国政府负责疾病预防控制的主要是疾病预防控制中心（CDC），美国CDC在亚特兰大，和埃默里大学是邻居，这样两家能够共同合作、互相兼职、开展研究，提高了CDC的科研水平。同时，CDC员工的薪资待遇水平也很有竞争力。而在中国，高校和CDC的合作并不密切。公共卫生的进步，离不开高校和疾控中心的紧密联动，促进学科理论与实践协同发展。
......
本次疫情也突显出应急战略储备不足的问题，医用防护物资的匮乏，不仅威胁到一线医务人员和工作人员的生命安全，更会对社会造成不良影响。国家必须建立完善的医疗物资战略储备管理体系。一是要建立健全制度，规范地对战略物资的储备、调动工作进行管理。二是要确保充足的储备，将相关的企业纳入到应急体系中管理，同时加大对企业的支持力度。
待遇低，地位低，没有话语权，周而复始。
角度不一样吧。
作为民众，怎么不满意都是有道理的。
但是各国同行之间，总会羡慕别人一些先进的方面吧，比如说权限，机制，人才，薪资，funding等等。
无论有些舆论怎么吹，我相信在很长一段时间内，在中国，实干的人还是会以美国为学习的榜样的。
查了一下，原来她就是去年MD ANDERSON新闻里的那个女科学家啊。
刚才自己跑群里发了原文，真是人才啊
原来是这个意思...我看简介任职期到2015，就没联想到去年的新闻。
所以她到底啥情况？
[url=https://www.bloomberg.com/news/features/2019-06-13/the-u-s-is-purging-chinese-americans-from-top-cancer-research]https://www.bloomberg.com/news/features/2019-06-13/the-u-s-is-purging-chinese-americans-from-top-cancer-research[/url]
It contained findings that she’d improperly shared confidential information and accepted a half-dozen advisory roles at medical institutions in China.
One of the program’s tag lines: “Cancer knows no borders.”
Except, it turns out, the borders around China. In January, Wu, an award-winning epidemiologist and naturalized American citizen, quietly stepped down as director of the Center for Public Health and Translational Genomics at the University of Texas MD Anderson Cancer Center after a three-month investigation into her professional ties in China. Her resignation, and the departures in recent months of three other top Chinese American scientists from Houston-based MD Anderson, stem from a Trump administration drive to counter Chinese influence at U.S. research institutions. The aim is to stanch China’s well-documented and costly theft of U.S. innovation and know-how. The collateral effect, however, is to stymie basic science, the foundational research that underlies new medical treatments. Everything is commodified in the economic cold war with China, including the struggle to find a cure for cancer.
Yea...just wonder if there more behind the scene.
She still approves the American approach though, understandably.